{"info": {"address1": "One IDEXX Drive", "city": "Westbrook", "state": "ME", "zip": "04092", "country": "United States", "phone": "207 556 0300", "fax": "207 556 4346", "website": "https://www.idexx.com", "industry": "Diagnostics & Research", "sector": "Healthcare", "longBusinessSummary": "IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; OPTI SARS-CoV-2 RT-PCR test kit for human COVID-19 testing; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.", "fullTimeEmployees": 10780, "companyOfficers": [{"maxAge": 1, "name": "Mr. Jonathan J. Mazelsky", "age": 61, "title": "Pres, CEO & Director", "yearBorn": 1961, "fiscalYear": 2022, "totalPay": 2038099, "exercisedValue": 15145850, "unexercisedValue": 42224584}, {"maxAge": 1, "name": "Mr. Brian P. McKeon", "age": 60, "title": "CFO, Exec. VP & Treasurer", "yearBorn": 1962, "fiscalYear": 2022, "totalPay": 1060641, "exercisedValue": 258686, "unexercisedValue": 15451343}, {"maxAge": 1, "name": "Mr. James F. Polewaczyk", "age": 58, "title": "Exec. VP & Chief Commercial Officer", "yearBorn": 1964, "fiscalYear": 2022, "totalPay": 889991, "exercisedValue": 0, "unexercisedValue": 5444937}, {"maxAge": 1, "name": "Mr. Michael J. Lane", "age": 54, "title": "Exec. VP and GM of Reference Laboratories & Information Technology", "yearBorn": 1968, "fiscalYear": 2022, "totalPay": 891096, "exercisedValue": 0, "unexercisedValue": 3617483}, {"maxAge": 1, "name": "Dr. Nimrata Khatra Hunt P.E., Ph.D.", "age": 53, "title": "Exec. VP of Strategy, Sector Devel. & Global Operations", "yearBorn": 1969, "fiscalYear": 2022, "totalPay": 887768, "exercisedValue": 0, "unexercisedValue": 2864964}, {"maxAge": 1, "name": "Mr. John  Hart", "title": "Sr. VP of Global Operations", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jeffery D. Chadbourne", "age": 46, "title": "Sr. Director of Accounting & Financial Reporting", "yearBorn": 1976, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Martin  Smith Ph.D.", "age": 54, "title": "Exec. VP & CTO", "yearBorn": 1968, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ken  Grady", "title": "Sr. VP & Chief Information Officer", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sharon E. Underberg", "age": 61, "title": "Exec. VP, Gen. Counsel, & Corp. Sec.", "yearBorn": 1961, "fiscalYear": 2020, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 2, "compensationRisk": 2, "shareHolderRightsRisk": 9, "overallRisk": 6, "governanceEpochDate": 1680307200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 2, "previousClose": 481.52, "open": 485.26, "dayLow": 479.23, "dayHigh": 485.26, "regularMarketPreviousClose": 481.52, "regularMarketOpen": 485.26, "regularMarketDayLow": 479.23, "regularMarketDayHigh": 485.26, "payoutRatio": 0.0, "beta": 1.193771, "trailingPE": 59.816372, "forwardPE": 44.109787, "volume": 308774, "regularMarketVolume": 308774, "averageVolume": 457411, "averageVolume10days": 390230, "averageDailyVolume10Day": 390230, "bid": 0.0, "ask": 0.0, "bidSize": 800, "askSize": 900, "marketCap": 40002846720, "fiftyTwoWeekLow": 317.06, "fiftyTwoWeekHigh": 517.91, "priceToSalesTrailing12Months": 11.879715, "fiftyDayAverage": 482.4014, "twoHundredDayAverage": 414.5493, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "enterpriseValue": 41357541376, "profitMargins": 0.20166999, "floatShares": 82046150, "sharesOutstanding": 82903400, "sharesShort": 1757539, "sharesShortPriorMonth": 1712434, "sharesShortPreviousMonthDate": 1677542400, "dateShortInterest": 1680220800, "sharesPercentSharesOut": 0.0212, "heldPercentInsiders": 0.00934, "heldPercentInstitutions": 0.92854, "shortRatio": 4.71, "shortPercentOfFloat": 0.0238, "impliedSharesOutstanding": 0, "bookValue": 7.344, "priceToBook": 65.64815, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1672444800, "earningsQuarterlyGrowth": 0.058, "netIncomeToCommon": 679089024, "trailingEps": 8.06, "forwardEps": 10.93, "pegRatio": 2.79, "lastSplitFactor": "2:1", "lastSplitDate": 1434412800, "enterpriseToRevenue": 12.282, "enterpriseToEbitda": 40.921, "52WeekChange": -0.060908854, "SandP52WeekChange": -0.06829989, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "IDXX", "underlyingSymbol": "IDXX", "shortName": "IDEXX Laboratories, Inc.", "longName": "IDEXX Laboratories, Inc.", "firstTradeDateEpochUtc": 677511000, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "f576b05b-2a7f-3f70-9980-7b0489373c04", "messageBoardId": "finmb_29729", "gmtOffSetMilliseconds": -14400000, "currentPrice": 482.12, "targetHighPrice": 600.0, "targetLowPrice": 500.0, "targetMeanPrice": 560.13, "targetMedianPrice": 570.0, "recommendationMean": 2.4, "recommendationKey": "buy", "numberOfAnalystOpinions": 8, "totalCash": 112546000, "totalCashPerShare": 1.358, "ebitda": 1010665024, "totalDebt": 1470038016, "quickRatio": 0.488, "currentRatio": 0.891, "totalRevenue": 3367323904, "debtToEquity": 241.49, "revenuePerShare": 40.268, "returnOnAssets": 0.21672001, "returnOnEquity": 1.04577, "grossProfits": 2004338000, "freeCashflow": 328162880, "operatingCashflow": 542984000, "earningsGrowth": 0.091, "revenueGrowth": 0.034, "grossMargins": 0.59523, "ebitdaMargins": 0.30014, "operatingMargins": 0.26691, "financialCurrency": "USD", "trailingPegRatio": 5.3827}, "news": [{"uuid": "f2fdbdf6-cdc7-371a-90aa-7181e20dc3ba", "title": "3 Reasons to Retain Merit Medical (MMSI) Stock in Your Portfolio", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/3-reasons-retain-merit-medical-153203056.html", "providerPublishTime": 1681831923, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/Bwjibxk8IIsM7dLPsV1mcQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/08380da297340a988e9902fee4e753cb", "width": 635, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/aJldi5BtSBx2y_HUyU_s6w--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/08380da297340a988e9902fee4e753cb", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["MMSI", "HSIC", "IDXX", "MASI"]}, {"uuid": "7d0e7a98-98d7-3748-b9e0-2f619145cd01", "title": "Those who invested in IDEXX Laboratories (NASDAQ:IDXX) five years ago are up 143%", "publisher": "Simply Wall St.", "link": "https://finance.yahoo.com/news/those-invested-idexx-laboratories-nasdaq-130027716.html", "providerPublishTime": 1681477227, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/qrnhoA9Y9l_fYJBd0ck5WA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/983f2bdfe32b19227b1d118c45bf4f09", "width": 1194, "height": 432, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/6iRuoNg6exhoisM46ySxQQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/983f2bdfe32b19227b1d118c45bf4f09", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["IDXX"]}, {"uuid": "13be4d1c-5353-396b-a65b-880d45d2d957", "title": "IDEXX Laboratories to Release 2023 First Quarter Financial Results", "publisher": "Business Wire", "link": "https://finance.yahoo.com/news/idexx-laboratories-release-2023-first-190000221.html", "providerPublishTime": 1681412400, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/v6BAMhEDoteVBoK6PFC_ug--~B/aD04ODt3PTQ4MDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/business-wire.com/dfa7a036dde205fa9876d05f45ccbe52", "width": 480, "height": 88, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/sWXACl8hG4BvrHrj7FZkAA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/dfa7a036dde205fa9876d05f45ccbe52", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["IDXX"]}, {"uuid": "5d902626-3eec-3afb-a561-bc55121ad238", "title": "ALC vs. IDXX: Which Stock Is the Better Value Option?", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/alc-vs-idxx-stock-better-154003442.html", "providerPublishTime": 1681314003, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/wbCMwMtKIoXj_iQA0ego4g--~B/aD01MDY7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/1154d43aaeb65735a640003549116295", "width": 900, "height": 506, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/Gkx1uVeFgGgcGf5Jyi6uoA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/1154d43aaeb65735a640003549116295", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["IDXX"]}, {"uuid": "b4b2becb-d8f8-344d-a73e-3e1e9eb89b98", "title": "Here's Why You Should Invest in IDEXX (IDXX) Stock Right Now", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/heres-why-invest-idexx-idxx-150003545.html", "providerPublishTime": 1681138803, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/.cFExAtq.C.oud6sX39cog--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/f21818c32cbc40e4ff1ee29342da1830", "width": 635, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/cF4uSOGjkfWEvmk4.sKSBw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/f21818c32cbc40e4ff1ee29342da1830", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["IDXX", "HOLX", "HSIC", "AVNS"]}, {"uuid": "671049c3-dfe0-30bf-ba65-8bd6477b30bd", "title": "What Is IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Share Price Doing?", "publisher": "Simply Wall St.", "link": "https://finance.yahoo.com/news/idexx-laboratories-inc-nasdaq-idxx-110043374.html", "providerPublishTime": 1680778843, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/qrnhoA9Y9l_fYJBd0ck5WA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/983f2bdfe32b19227b1d118c45bf4f09", "width": 1194, "height": 432, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/6iRuoNg6exhoisM46ySxQQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/983f2bdfe32b19227b1d118c45bf4f09", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["IDXX"]}, {"uuid": "83c4b318-8120-3c08-8012-4475b552d016", "title": "Strong Q3 Results Pushed IDEXX Laboratories (IDXX) in Q4", "publisher": "Insider Monkey", "link": "https://finance.yahoo.com/news/strong-q3-results-pushed-idexx-113528413.html", "providerPublishTime": 1680262528, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/EuTtZj8VhLAO_VlQSmCijg--~B/aD02Njg7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/2e6d787cadb163790149ab2e9cd77c4a", "width": 1000, "height": 668, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/MHhVcOPKZs1WSBKa2qf2LA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/2e6d787cadb163790149ab2e9cd77c4a", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["IDXX"]}, {"uuid": "587e7ba7-e15a-3303-b331-1c22afb03a77", "title": "These 4 Measures Indicate That IDEXX Laboratories (NASDAQ:IDXX) Is Using Debt Reasonably Well", "publisher": "Simply Wall St.", "link": "https://finance.yahoo.com/news/4-measures-indicate-idexx-laboratories-120027750.html", "providerPublishTime": 1679140827, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/qrnhoA9Y9l_fYJBd0ck5WA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/983f2bdfe32b19227b1d118c45bf4f09", "width": 1194, "height": 432, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/6iRuoNg6exhoisM46ySxQQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/983f2bdfe32b19227b1d118c45bf4f09", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["IDXX"]}]}